BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 31117909)

  • 1. Three Recent Cases of Likely Methadone Cross-Reactivity With Vortioxetine.
    Kieran K
    J Am Psychiatr Nurses Assoc; 2019; 25(3):170. PubMed ID: 31117909
    [No Abstract]   [Full Text] [Related]  

  • 2. Vortioxetine use may cause false positive immunoassay results for urine methadone.
    Uljon S; Kataria Y; Flood JG
    Clin Chim Acta; 2019 Dec; 499():1-3. PubMed ID: 31469980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-positive results in the detection of methadone in urines of patients treated with psychotropic substances.
    Lancelin F; Kraoul L; Flatischler N; Brovedani-Rousset S; Piketty ML
    Clin Chem; 2005 Nov; 51(11):2176-7. PubMed ID: 16244295
    [No Abstract]   [Full Text] [Related]  

  • 4. False-positive methadone urine drug screen in a patient treated with quetiapine.
    Lasić D; Uglesić B; Zuljan-Cvitanović M; Supe-Domić D; Uglesić L
    Acta Clin Croat; 2012 Jun; 51(2):269-72. PubMed ID: 23115954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-positive methadone drug screens during quetiapine treatment.
    Fischer M; Reif A; Polak T; Pfuhlmann B; Fallgatter AJ
    J Clin Psychiatry; 2010 Dec; 71(12):1696. PubMed ID: 21190642
    [No Abstract]   [Full Text] [Related]  

  • 6. Quetiapine cross reactivity with urine methadone immunoassays.
    Widschwendter CG; Zernig G; Hofer A
    Am J Psychiatry; 2007 Jan; 164(1):172. PubMed ID: 17202566
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of some psychotherapeutic drugs and their metabolites in urine.
    Garriott JC; Stolman A
    Clin Toxicol; 1971 Jun; 4(2):225-43. PubMed ID: 5097493
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of a latex agglutination-inhibition slide pregnancy test (Pregnosis).
    Horwitz CA; Jerome E; Paulson C; Stearns J; Ross R; Ward PC
    Obstet Gynecol; 1974 May; 43(5):693-6. PubMed ID: 4822653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Effect of Vortioxetine on the Pharmacokinetics and Pharmacodynamics of Ethanol, Diazepam, and Lithium.
    Chen G; Nomikos GG; Affinito J; Zhao Z
    Clin Pharmacokinet; 2016 Sep; 55(9):1115-27. PubMed ID: 27048210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False methadone-positive urine drug screens in patients treated with quetiapine.
    Cherwinski K; Petti TA; Jekelis A
    J Am Acad Child Adolesc Psychiatry; 2007 Apr; 46(4):435-436. PubMed ID: 17420676
    [No Abstract]   [Full Text] [Related]  

  • 11. EMIT dau: methadone false positive with creatinine interference.
    Fucci N
    Forensic Sci Int; 2005 Feb; 148(1):81. PubMed ID: 15607595
    [No Abstract]   [Full Text] [Related]  

  • 12. False-positive immunochemical screen for methadone attributable to metabolites of verapamil.
    Lichtenwalner MR; Mencken T; Tully R; Petosa M
    Clin Chem; 1998 May; 44(5):1039-41. PubMed ID: 9590378
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription compliance or illicit designer drug abuse?
    Petrie MS; Lynch KL; Wu AH; Steinhardt AA; Horowitz GL
    Clin Chem; 2012 Dec; 58(12):1631-4. PubMed ID: 23193148
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to a report on false-positive results in a methadone enzyme immunoassay.
    Tsay YG; Khosropour P
    Clin Chem; 1998 Oct; 44(10):2221-2. PubMed ID: 9761270
    [No Abstract]   [Full Text] [Related]  

  • 15. Does therapeutic use of tapentadol cause false-positive urine screens for methadone or opiates?
    Mullins ME; Hock K; Scott MG
    Clin Toxicol (Phila); 2015 Jun; 53(5):493-4. PubMed ID: 25951899
    [No Abstract]   [Full Text] [Related]  

  • 16. Liquid-solid extraction of lyophilized biological material for forensic analysis. I. Application to urine samples for detection of drugs of abuse.
    Broich JR; Hoffman DB; Goldner SJ; Andryauskas S; Umberger CJ
    J Chromatogr; 1971 Dec; 63(2):309-12. PubMed ID: 4400802
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial.
    Cao B; Park C; Rosenblat JD; Chen Y; Iacobucci M; Subramaniapillai M; Mansur RB; Zuckerman H; Lee Y; McIntyre RS
    J Psychopharmacol; 2019 Nov; 33(11):1388-1394. PubMed ID: 31530216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder.
    Jain R; Mahableshwarkar AR; Jacobsen PL; Chen Y; Thase ME
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):313-21. PubMed ID: 22963932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome.
    Christensen MC; Munro V
    Curr Med Res Opin; 2018 Apr; 34(4):593-600. PubMed ID: 29235884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vortioxetine for attention deficit hyperactivity disorder in adults: A randomized, double-blind, placebo-controlled, proof-of-concept study.
    Biederman J; Lindsten A; Sluth LB; Petersen ML; Ettrup A; Eriksen HF; Fava M
    J Psychopharmacol; 2019 Apr; 33(4):511-521. PubMed ID: 30843450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.